XML 115 R103.htm IDEA: XBRL DOCUMENT v3.25.3
Note 19 - Stock-based Compensation (Details Textual) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Apr. 25, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2018
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) 1,000,000           500,000
Proceeds (Used for) and Received from Settlement of Stock Awards       $ 344,000 $ 203,000    
Stock Appreciation Rights (SARs) [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)       10 years      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)       25,000   42,000  
Stock Appreciation Rights (SARs) [Member] | Share-Based Payment Arrangement, Tranche One [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage       20.00%      
Restricted Stock [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       5 years      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)       39,000   46,000  
Performance Shares [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       3 years      
Sharebased Compensation Arrangement by Share-based Payment Award Post Vesting Holding Period (Year)       1 year      
Share-based Compensation Arrangement by Share-based Payment Award Liquidity Discount       5.50% 5.80%    
Restricted Stock Units (RSUs) [Member] | Director [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       12 months      
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)   7,670 9,550        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Fair Value Granted   $ 539,000 $ 500,000